IQPC have gathered many high-level industry experts together to provide insights and unique solutions for the most common challenges faced within the industry today.

In a recent conversation John Kuczek, Associate Director of Contract Manufacturing at Biogen Idec discussed Vendor Selection and Capacity Utilization Rationalization. To hear the podcast in its entirety, listen here.

This is a must attend conference for pharmaceutical professionals to mitigate risks, ensure compliance, and improve efficiency for domestic and international outsourced manufacturing.

Industry Organizations: GlaxoSmithKline, Watson Laboratories, Agensys, Inc., Roche Contract Manufacturing Operating Unit, Novartis, Biogen Idec, Bausch & Lomb Pharmaceuticals, Johnson & Johnson and more.

The 10th Contract Manufacturing for Pharmaceuticals and Biotech conference is expected to attract high level professionals responsible for manufacturing and operations, outsourcing, supply chain, contract manufacturing and transfer, engineering, operational excellence, quality assurance and beyond.

Media Partners for the event include Future Pharmaceuticals, PMPS, Pharmaceutical Manufacturing, Pharmaceutical Outsourcing and Markets and Markets

For additional information, please visit www.pharmacontractmanufacturing.com or contact Karen Richardson at karen.richardson@iqpc.com or 646-378-6034.

IQPC produces more than 1,500 events annually around the world, and continues to grow. Founded in 1973, IQPC now has offices in major cities across five continents. IQPC leverages a global research base of best practices to produce a cross industry portfolio of conferences.